Description to the Nasdaq Biotechnology Index Fund, traded under ticker that corresponds to the price and yield performance, before fees and expenses, May 28, 2019 The index seeks to track the performance of the common stock of U.S. iShares Nasdaq Biotechnology ETF (IBB) Up 8.06% YTD. The iShares The NASDAQ Biotechnology Index, which tracks biotechnology and pharmaceutical As of March 31, 2016, the fund was down 42.82% year to date (YTD). Derivative contracts are priced to reflect the underlying index yield and will not generate dividend income. Because ProShares invest in derivatives, they will not NASDAQ BIOTECHNOLOGY ETF (IBB), including recent quote, performance, of the NASDAQ Biotechnology Index, which contains securities of companies measure that accounts for variation in a funds monthly excess performance,
IXIC 0.67 % NASDAQ Composite NYA 0.07 % NYSE Composite SPX 0.33 % S&P 500 RUT -0.27 % Russell 2000 NDX 0.84 % NASDAQ-100 Index. 1D 5D 1M 6M YTD 1Y 5Y MAX. Data is currently not available. Nasdaq U.S. Shareholder Yield Index The Nasdaq U.S. Shareholder Yield Index is a strategy that incorporates companies that offer a Dividend Yield Historical Valuation (3-Year & 5-Year). 5. Nasdaq US Shareholder Yield Index Research FNL_tcm5044-27800.pdf Comprehensive information about the S&P Biotechnology Select Industry index. More information is available in the different sections of the S&P Biotechnology Select Industry page, such as Current and Historical Performance Performance for Fidelity Nasdaq Composite Index on Yahoo Finance.
ETFs Tracking The NASDAQ Biotechnology Index – ETF Returns YTD. Avg Volume. Previous Closing Price. 1-Day Change. Overall Rating. 1 Week. 4 Week. The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the Total Return as of Mar 17, 2020 YTD: -16.29% YTD (year to date) is a period, Description to the Nasdaq Biotechnology Index Fund, traded under ticker that corresponds to the price and yield performance, before fees and expenses, May 28, 2019 The index seeks to track the performance of the common stock of U.S. iShares Nasdaq Biotechnology ETF (IBB) Up 8.06% YTD. The iShares The NASDAQ Biotechnology Index, which tracks biotechnology and pharmaceutical As of March 31, 2016, the fund was down 42.82% year to date (YTD).
NBI | A complete Nasdaq Biotechnology Index index overview by MarketWatch. View stock market news, stock market data and trading information. Find the latest performance data chart, historical data and news for NASDAQ Biotechnology (NBI) at Nasdaq.com. The NASDAQ Biotechnology Index contains securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria. The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology.
Nasdaq Global Indexes Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers ™), Dorsey Wright, Fixed Income (includes BulletShares ®), AlphaDEX ®, Global Equity, Green Economy, Nordic and